RBC Capital raises Avantor stock price target on turnaround progress
RBC Capital raised its price target for Avantor Inc. (NYSE:AVTR) to $17.00 from $14.00, citing progress in management turnaround and revenue recovery, though margins remain pressured. The stock is near its 52-week high after a 118% surge. Avantor's Q3 2026 earnings and revenue beat estimates, but the company maintained a cautious outlook.
How this was made
The 30-second read
Why it matters
The upgrade could attract buying interest, especially from investors seeking exposure to the biopharma supply chain.
Market read
Analyst target raise on earnings beat provides a fresh catalyst for AVTR, suggesting short‑term upside.
What to watch
Potential headwinds from cost‑inflation and competitive pricing in the VWR and BMP franchises.
Background
RBC Capital upgraded Avantor (AVTR) to a Sector Perform rating with a new $17 price target after the company posted Q3 2026 earnings that beat consensus.
Ticker impact
RBC Capital raised its price target on Avantor to $17 from $14 after reporting Q3 2026 earnings that beat expectations.
likely upward pressure as investors price in the target raise and earnings beat
The price target increase reflects confidence in revenue recovery and margin improvement despite ongoing pressures.
Market effects
Positive signal for the life‑sciences supply sector as Avantor's turnaround may lift peers.
U.S. market focus; limited regional effect.
Modest; mainly impacts investors tracking biotech supply chains.
Counterpoint
Margin pressure remains high; the target raise may be premature.
Key entities
- companyAvantor Inc.
Life‑sciences and advanced technologies supplier.
- analystRBC Capital
Equity research firm that raised the price target.
